=================================== ----------------------------
FORM 4 OMB APPROVAL
=================================== ----------------------------
|_| Check this box if no longer OMB Number
subject to Section 16. Form 4 Expires:
or Form 5 obligations may Estimated average burden
continue. See Instruction 1(b). hours per response...0.5
=================================== ----------------------------
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935
or Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
<TABLE>
<S> <C> <C>
------------------------------------------ ------------------------------------------- ------------------------------------------
1. Name and Address of Reporting Person* 2. Issuer Name and Ticker or Trading Symbol 6. Relationship of Reporting Person to
Issuer (Check all applicable)
Vilmorin Clause & Cie Agritope, Inc. (AGTO) _____ Director ___X__10% Owner
------------------------------------------ ------------------ ------------------------
(Last) (First) (Middle) 3. IRS or Social 4. Statement for _____ Officer (give title below)
Security Number Month/Year
B.P. 1 of Reporting September 2000 _____ Other (specify below)
Person ------------------------
------------------------------------------ (Voluntary)
(Street) 5. If Amendment, ---------------------------------
N/A Date of Original 7. Individual or Joint/Group Filing
63720 Chappes, France (Month/Year) (Check Applicable Line)
------------------------------------------ ___ Form filed by One Reporting Person
(City) (State) (Zip) _X_ Form filed by More than One
Reporting Person
------------------ ------------------------ ------------------------------------------
</TABLE>
<TABLE>
<CAPTION>
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
---------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
-------------------------- ---------- ------------ ----------------------------------- --------------- ------------- ---------------
1. Title of Security 2. Trans- 3. Trans- 4. Securities Acquired (A) 5. Amount of 6.Owner- 7. Nature of
(Instr. 3) action action or Disposed of (D) Securities ship Indirect
Date Code (Instr. 3, 4 and 5) Beneficially Form: Beneficial
(Instr. 8) owned at Direct Ownership
(Month/ End of Month (D) or (Instr. 4)
Day/ (Instr. 3 Indirect
Year) and 4) (I)
------------ ---------------------------------- (Instr.4)
------ ----- ------------- ------ -------------
Code V Amount (A)or Price
(D)
-------------------------- ---------- ------ ----- ------------- ------ -------------- ---------------- ------------- --------------
-------------------------- ---------- ------ ----- ------------- ------ -------------- ---------------- ------------- --------------
-------------------------- ---------- ------ ----- ------------- ------ -------------- ---------------- ------------- --------------
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
SEC 1474 (7-96)
* If the form is filed by more than one reporting person, see Instruction
4(b)(v).
</TABLE>
Page 1 of 3
<PAGE>
<TABLE>
<CAPTION>
FORM 4 (continued)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially
Owned (e.g., puts, calls, warrants, options, convertible securities)
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
----------------- ---------- ------- ------- ----------------- ------------ ------------------ -------- ---------- ------- ---------
1.Title of Deri- 2.Conver- 3.Trans-4.Trans-5.Number of Deri- 6.Date Exer- 7.Title and Amount 8.Price 9.Number 10.Own- 11.Nature
vative Security sion or action action vative Securities cisable and of Underlying Sec- of Deri- of Deri- ership of Bene-
(Instr. 3) Exercise Date Code Acquired (A) or Expiration urities vative vative Form of ficial
Price of (Month/ (Instr. Disposed of (D) Date (Instr. 3 and 4) Security Securities Deriva- Indirect
Deriva- Day/ 8) (Instr.3,4 and 5) (Month/Day (Instr. Benefi- tive Ownership
tive Year) Year) 5) cially Securi (Instr.
Security Owned at ty: Di- 4)
End of rect (D)
Month or In-
(Instr. 4) direct
(I)
(Instr.
4)
------- ----------------- ------------- -----------------
---- -- -------- -------- ------ ------ ------- ---------
Code V (A) (D) Date Expir- Title Amount or
Exer- ation Number of
cis- Date Shares
able
----------------- ---------- ------- -------- ------- -------- ------ ------ ------- --------- -------- ---------- ------- ---------
Series A Convertible Common
Preferred Stock N/A 09/06/00 J(1) -- -- 564,285 (2) N/A Stock 564,285 (1) 564,285 I (4)
----------------- ---------- ------- -------- ------- -------- ------ ------ ------- --------- -------- ---------- ------- ---------
Warrants to Purchase
Series A Convertible Common
Preferred Stock $7.00 09/06/00 J(1) -- -- 87,500 (3) 9/28/04 Stock 87,500 (1) 87,500 I (4)
----------------- ---------- ------- -------- ------- -------- ------ ------ ------- --------- -------- ---------- ------- ---------
Explanation of Responses:
(1) On September 6, 2000, Vilmorin contributed to the capital of American Bio Corp., its wholly-owned subsidiary, all of Vilmorin's
interest in Agritope, consisting of 564,285 shares of Series A Convertible Preferred Stock and 87,500 warrants to purchase Series A
Convertible Preferred Stock. No consideration was paid by American Bio Corp. for the securities.
(2) The shares of Series A Preferred Stock are convertible, at the option of the holder thereof, at any time and from time to time,
without the payment of additional consideration by the holder thereof.
(3) The warrants are exercisable at any time prior to 5 p.m., U.S. Pacific Time, on the expiration date.
(4) As a result of the subject transaction, Vilmorin beneficially owns the securities indirectly through American Bio Corp., its
wholly-owned subsidiary.
</TABLE>
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
VILMORIN CLAUSE & CIE
By: /s/Pierre Lefebvre 9/30/00
Name: Pierre Lefebvre Date
Title: CEO
**Signature of Reporting Person
Note: File three copies of this Form, one of which must be manually
signed. If space provided is insufficient, see Instruction 6 for
procedure.
Page 2 of 3
<PAGE>
Attachment to Form 4
Name of Designated Reporting Person: Vilmorin Clause & Cie
Statement for Month/Year: September 2000
Issuer Name and Ticker or Trading Symbol: Agritope, Inc. (AGTO)
The names and addresses of the other Reporting Persons who have joined in this
filing are as follows:
Name Address
Groupe Limagrain Holding S.A. B.P. 1
63720 Chappes, France
Societe Cooperative Agricole Limagrain B.P. 1
63720 Chappes, France
Vilmorin Clause & Cie ("Vilmorin") is a subsidiary of Groupe Limagrain Holding
S.A. ("Group Limagrain"), and Groupe Limagrain is, in turn, a subsidiary of
Societe Cooperative Agricole Limagrain (the "Cooperative"). By virtue of these
parent-subsidiary relationships, each of Groupe Limagrain and the Cooperative is
an indirect beneficial owner of the Agritope securities beneficially owned
directly by Vilmorin, as described in the attached Form 4.
Groupe Limagrain Holding S.A.
By: /s/ Alain Catala
Name: Alain Catala
Title: CEO
Societe Cooperative Agricole Limagrain
By: /s/ Alain Catala
Name: Alain Catala
Title: CEO
Page 3 of 3
